{"product_id":"greencrosshealth-five-forces-analysis","title":"Green Cross Health Porter's Five Forces Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eA Must-Have Tool for Decision-Makers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eGreen Cross Health faces moderate buyer power, intensifying competition from national pharmacy chains, and regulatory pressures that shape margins and growth avenues; supplier leverage and digital disruption add tactical complexity to its community-focused model.\u003c\/p\u003e\n\u003cp\u003eThis brief snapshot only scratches the surface. Unlock the full Porter's Five Forces Analysis to explore Green Cross Health’s competitive dynamics, market pressures, and strategic advantages in detail.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003euppliers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePharmac Procurement Centralization\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePharmac, New Zealand’s pharmaceutical procurement agency, centralizes purchases for ~95% of subsidised medicines, cutting suppliers’ bargaining power and limiting manufacturers’ ability to price above set rates.\u003c\/p\u003e\n\u003cp\u003eBecause Pharmac sets subsidies and prices, Green Cross Health faces stable drug costs—retail cost inflation for subsidised drugs has averaged under 2% annually since 2019—protecting it from global price shocks.\u003c\/p\u003e\n\u003cp\u003eThat protection reduces margin risk but narrows brand choice in stores: a 2024 Ministry of Health review found formulary consolidation reduced listed brands by ~18%, constraining retail differentiation.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eWholesale Distribution Concentration\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGreen Cross Health depends on a few large wholesalers—notably EBOS Group (NZX:EBOS), which held ~28% market share in Australasian healthcare distribution in 2024—giving suppliers leverage over delivery timing and service fees for Unichem and Life Pharmacy.\u003c\/p\u003e\n\u003cp\u003eIn 2024 EBOS reported NZD 4.8bn revenue and 4.6% EBIT margin, so a 5% price rise or a 3‑day logistics delay could cut pharmacy margins by ~0.5–1.2 percentage points and disrupt inventory turnover.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eQualified Workforce Scarcity\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eThe supply of registered pharmacists and specialized nurses in New Zealand remained tight in late 2025, with pharmacist vacancy rates near 6% and nursing shortages adding ~4% to locum costs, giving staff strong bargaining power.\u003c\/p\u003e\n\u003cp\u003eRising wage expectations—pharmacist median pay up ~8% year-on-year to NZD 95,000 in 2025—and richer benefits push Green Cross Health’s operating expenses higher.\u003c\/p\u003e\n\u003cp\u003eGreen Cross Health needs ongoing investment in recruitment, retention, and training; failing that, clinic staffing gaps risk regulatory non-compliance and lost revenue.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialized Technology Providers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSpecialized vendors for clinical management software and secure patient-data platforms give Green Cross Health rising supplier power because switching costs and workflow disruption are high; 2024 NZ Health IT surveys show 62% of GP practices cite integration cost as main barrier to change.\u003c\/p\u003e\n\u003cp\u003eAs primary care shifts to integrated digital records, these suppliers command premiums—cybersecurity and interoperability add 8–15% to vendor fees per contract, per 2023 NZ procurement reports.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eDependence: core clinical software\u003c\/li\u003e\n\u003cli\u003eHigh switching cost: 62% practices\u003c\/li\u003e\n\u003cli\u003ePremiums: +8–15% for security\/interop\u003c\/li\u003e\n\u003cli\u003eRisk: vendor lock-in, pricing leverage\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Product Diversification\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSuppliers of premium beauty and wellness brands exert moderate power over Life Pharmacy due to exclusivity; a major brand exit or shift to direct-to-consumer could cut store footfall by an estimated 3–7% based on NZ retail cosmetics trends in 2024.\u003c\/p\u003e\n\u003cp\u003eGreen Cross Health limits supplier power via a diversified supplier mix across 150+ Life Pharmacy stores and group procurement, so no single brand can set network-wide terms.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eModerate supplier power: exclusivity drives leverage\u003c\/li\u003e\n\u003cli\u003eRisk: 3–7% potential footfall loss if major brand exits\u003c\/li\u003e\n\u003cli\u003eMitigation: 150+ stores, broad supplier portfolio, group buying\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePharmac caps drug pricing; EBOS \u0026amp; IT vendors retain delivery, wage and lock‑in leverage\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePharmac’s central purchasing (~95% subsidised drugs) caps suppliers’ pricing power, keeping subsidised drug inflation \u0026lt;2% pa since 2019 and protecting margins; EBOS (28% Australasian distribution share, NZD 4.8bn revenue in 2024) and clinical IT vendors (62% practices cite high switch cost) still wield delivery, wage (pharmacist median NZD 95,000 in 2025) and lock‑in leverage.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePharmac coverage\u003c\/td\u003e\n\u003ctd\u003e~95%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSubsidised drug inflation\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;2% pa (since 2019)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEBOS 2024 revenue\u003c\/td\u003e\n\u003ctd\u003eNZD 4.8bn (28% share)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePharmacist median pay 2025\u003c\/td\u003e\n\u003ctd\u003eNZD 95,000\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHigh switch-cost IT practices\u003c\/td\u003e\n\u003ctd\u003e62%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eTailored Porter's Five Forces for Green Cross Health, uncovering key competitive drivers, buyer and supplier power, substitute threats, and entry barriers to assess pricing influence, profitability risks, and strategic defenses.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eOne-sheet Porter's Five Forces for Green Cross Health—quickly spot competitive threats and relief strategies to guide pharmacy and primary-care decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGovernment Funding Dominance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe primary customer for Green Cross Health is the New Zealand government via Te Whatu Ora, which funded about NZD 2.2 billion in primary care subsidies in FY2024, creating a monopsony-like market where the state sets GP and dispensing reimbursement rates.\u003c\/p\u003e\n\u003cp\u003eThat pricing power limits Green Cross Health’s ability to raise fees; its medical and community health revenue—around NZD 300m in FY2024—is highly sensitive to public health policy and budget shifts.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRetail Consumer Price Sensitivity\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eIn retail pharmacy, customer bargaining power is high: 72% of New Zealand shoppers compare pharmacy prices online in 2024, pressuring margins on vitamins, skincare and OTCs.\u003c\/p\u003e\n\u003cp\u003eEasy price comparison and online alternatives force Green Cross Health to use Living Rewards and targeted discounts to retain customers and sustain premium pricing on 15–20% of SKU lines.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIncreased Patient Mobility\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eUrban patients can choose among 4,000+ clinics and 3,200+ community pharmacies in New Zealand, so Green Cross Health faces high switching risk if wait times or service fall; a 2024 survey found 42% of urban patients would change providers after one poor visit. Digital booking and e-prescription platforms grew 28% in 2023, making cross-network switching easier, so Green Cross must prioritize faster access, seamless digital booking, and prescription continuity to retain volumes and revenue.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGrowth of Private Health Insurance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eAs private health insurance uptake in New Zealand rose to about 34% of the population by 2024, insurers gained leverage to steer members toward contracted providers, pressuring prices for specialist and rehab services.\u003c\/p\u003e\n\u003cp\u003eInsurers negotiate bulk rates and preferred-provider deals that can compress Green Cross Health margins; aligning services and reporting to insurer requirements is key to capture higher-paying insured patients.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e~34% insured (2024)\u003c\/li\u003e\n\u003cli\u003eInsurer-negotiated bulk rates reduce margins\u003c\/li\u003e\n\u003cli\u003ePreferred-provider status drives patient volumes\u003c\/li\u003e\n\u003cli\u003eAlign offerings\/reporting to win high-value patients\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Literacy and Self-Care\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eConsumers increasingly self-diagnose and buy health products online, with 78% of NZ adults using digital health info in 2024, shifting purchase power from pharmacists to shoppers.\u003c\/p\u003e\n\u003cp\u003eCustomers now request specific brands and OTC remedies after online research, reducing reliance on pharmacist advice and pressuring margins.\u003c\/p\u003e\n\u003cp\u003eGreen Cross Health must adopt consultative, personalized services—telehealth, targeted advice, loyalty data—to add value beyond transactions.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e78% NZ adults used digital health info (2024)\u003c\/li\u003e\n\u003cli\u003eHigher SKU-request rate lowers add-on sales\u003c\/li\u003e\n\u003cli\u003eTelehealth + loyalty raises retention\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePricing pressure and digital shift force Green Cross Health into loyalty, telehealth, insurer ties\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCustomers (mainly Te Whatu Ora) have strong pricing power—NZD 2.2bn primary care subsidies in FY2024—limiting fee growth; retail shoppers and insurers (34% insured in 2024) further compress margins via price comparison and preferred-provider deals; digital self-diagnosis (78% of adults in 2024) shifts purchase power online, raising switching risk and forcing Green Cross Health toward loyalty, telehealth, and insurer-aligned reporting to protect volumes.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024 value\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eGovernment primary care subsidies\u003c\/td\u003e\n\u003ctd\u003eNZD 2.2bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGreen Cross medical\/community revenue\u003c\/td\u003e\n\u003ctd\u003e~NZD 300m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePrivate insurance uptake\u003c\/td\u003e\n\u003ctd\u003e34%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAdults using digital health info\u003c\/td\u003e\n\u003ctd\u003e78%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eUrban patient switching after one poor visit\u003c\/td\u003e\n\u003ctd\u003e42%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eSame Document Delivered\u003c\/span\u003e\u003cbr\u003eGreen Cross Health Porter's Five Forces Analysis\u003c\/h2\u003e\n\u003cp\u003eThis preview shows the exact Green Cross Health Porter’s Five Forces analysis you'll receive immediately after purchase—no surprises, no placeholders, fully formatted and ready for use.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56747146609017,"sku":"greencrosshealth-five-forces-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/greencrosshealth-five-forces-analysis.png?v=1772195400","url":"https:\/\/matrixbcg.com\/products\/greencrosshealth-five-forces-analysis","provider":"MatrixBCG","version":"1.0","type":"link"}